Alex Wang, Ph.D.
Research Scientist I
Alex Wang is a research scientist I in the medicinal chemistry group in the Cancer Program at the Ó³»´«Ã½ of MIT and Harvard, working under the direction of J.T. Neal. The goal of his research is to understand the impact of variants of uncertain significance in cancer-associated genes in terms of how these variants affect gene function, tumorigenesis, and therapeutic response. He uses deep mutational scanning, where every possible amino acid change at each position in a protein is produced. Instead of just focusing on a handful of the most frequent hotspot mutations, this method allows him and his colleagues to systematically assess the function of every possible variant.
Wang joined the Ó³»´«Ã½ in 2019 after completing postdoctoral fellowships at Harvard Medical School and Dana-Farber Cancer Institute. He earned his Ph.D. in biochemistry and molecular and cell biology from Cornell University and holds a B.S. in chemistry from the University of Florida. During his undergraduate studies, he interned at NIH/NIAAA’s Laboratory of Neurogenetics.
Contact Alex Wang via email at alwang@broadinstitute.org
January 2021
